Skip to main content
logo
Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
5.67
+0.61 (12.06%)
At close: Mar 12, 2026, 4:00 PM EDT
5.85
+0.18 (3.17%)
After-hours: Mar 12, 2026, 7:44 PM EDT

Precision BioSciences Revenue

In the year 2025, Precision BioSciences had annual revenue of $34.26M, down -50.12%. Precision BioSciences had revenue of $34.20M in the quarter ending December 31, 2025, with 5,261.13% growth.

Revenue (ttm)
$34.26M
Revenue Growth
-50.12%
P/S Ratio
3.98
Revenue / Employee
$511,403
Employees
67
Market Cap
136.49M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202534.26M-34.43M-50.12%
Dec 31, 202468.70M19.97M40.98%
Dec 31, 202348.73M23.63M94.15%
Dec 31, 202225.10M-90.43M-78.28%
Dec 31, 2021115.53M91.24M375.72%
Dec 31, 202024.29M2.05M9.20%
Dec 31, 201922.24M11.36M104.34%
Dec 31, 201810.88M4.40M67.84%
Dec 31, 20176.48M-531.00K-7.57%
Dec 31, 20167.02M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Karyopharm Therapeutics146.07M
Spero Therapeutics40.55M
Sangamo Therapeutics32.88M
Innate Pharma14.84M
Fate Therapeutics6.65M
Equillium4.39M
Oramed Pharmaceuticals2.00M
Cardiff Oncology593.00K
Revenue Rankings

DTIL News

More News